← Evidence map

ArticleMultiple sclerosis and related disorders2021

COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab.

Fabio Buttari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33990054